About Endoluxe
Endoluxe is a company based in Atlanta (United States) founded in 2013 by Neal Patel. Endoluxe has raised $5.66 million across 4 funding rounds. Endoluxe offers products and services including Endoluxe Vision, Digital Health Platform, and Surgical Intelligence. Endoluxe operates in a competitive market with competitors including AI Medical Service, Magentiq Eye, Endovision, EndoMetric Corporation and Aurora Medical Technologies, among others.
- Headquarter Atlanta, United States
- Founders Neal Patel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.66 M (USD)
in 4 rounds
-
Latest Funding Round
$1 M (USD), Series A
Sep 19, 2022
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endoluxe
Endoluxe offers a comprehensive portfolio of products and services, including Endoluxe Vision, Digital Health Platform, and Surgical Intelligence.
Wireless system for visualizing and recording endoscopic procedures.
Cloud service for storing and sharing endoscopy videos securely.
Uses computer vision to provide insights during surgical procedures.
People of Endoluxe
Unlock access to complete
Unlock access to complete
Funding Insights of Endoluxe
Endoluxe has successfully raised a total of $5.66M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Endoluxe
Investment portfolio details for Endoluxe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endoluxe
Detailed financials for Endoluxe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endoluxe Comparisons
Peer comparison for Endoluxe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endoluxe
Endoluxe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AI Medical Service, Magentiq Eye, Endovision, EndoMetric Corporation and Aurora Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
|
| Locked | Locked | Locked |
Computer vision software is utilized for endoscopic medical procedures.
|
|
| Locked | Locked | Locked |
Real-time AI assistance is provided for endoscopy diagnostics.
|
|
| Locked | Locked | Locked |
Provides a digital tool for medical image analysis, assisting healthcare providers with accurate diagnostics.
|
|
| Locked | Locked | Locked |
Develops innovative suturing tools for endoscopic procedures in medical devices.
|
Detailed competitors of Endoluxe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endoluxe
Complete news archive for Endoluxe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endoluxe
Endoluxe was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Endoluxe is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Neal Patel is the current CEO of Endoluxe. They have also founded this company.
Endoluxe is a funded company, having raised a total of $5.66M across 4 funding rounds to date.
Endoluxe was founded in 2013 in Atlanta, United States, and operates in the medical device sector. Portable endoscopic visualization systems are developed by the company, compatible with analog endoscopes to enable white light and narrow-band imaging. Procedures can be performed in diverse settings through an integrated cloud-connected software suite that supports media storage and clinician access.
Endoluxe's top competitors include AI Medical Service, Magentiq Eye and Endovision.
Endoluxe offers Endoluxe Vision, Digital Health Platform, and Surgical Intelligence.